300233 金城醫藥
按盤價 
15.590 +0.490 (+3.245%)
15.590 +0.490 (+3.245%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 1,932,026 | -23.19% | 3,373,387 | 3,538,312 | 3,505,717 | 3,138,454 | |
| 減：營業總成本 | 1,891,362 | -18.94% | 3,103,164 | 3,293,668 | 3,133,449 | 2,918,647 | |
| 其中:營業成本 | 1,232,102 | -18.18% | 2,019,599 | 1,991,127 | 1,885,256 | 1,487,117 | |
| 財務費用 | 2,684 | 72.25% | (899) | 10,279 | 14,705 | 25,588 | |
| 資產減值損失 | (17,860) | 75.76% | (32,635) | (46,543) | (40,770) | (57,823) | |
| 公允價值變動收益 | (109) | -64.36% | 87 | (82) | (484) | (1,132) | |
| 投資收益 | 961 | -163.07% | (1,665) | 590 | 3,444 | 12,502 | |
| 其中：對聯營企業和合營企業的投資收益 | (162) | -60.67% | (403) | (730) | (471) | (872) | |
| 營業利潤 | 52,885 | -72.92% | 267,138 | 225,849 | 353,777 | 210,050 | |
| 利潤總額 | 50,578 | -74.32% | 268,448 | 225,408 | 345,966 | 196,550 | |
| 減：所得稅費用 | 16,980 | -51.26% | 60,713 | 32,097 | 60,091 | 73,466 | |
| 淨利潤 | 33,598 | -79.27% | 207,735 | 193,311 | 285,875 | 123,084 | |
| 減：非控股權益 | 2,021 | -81.71% | 10,955 | 18,602 | 12,510 | 15,100 | |
| 股東淨利潤 | 31,577 | -79.10% | 196,781 | 174,709 | 273,365 | 107,984 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.080 | -80.00% | 0.520 | 0.450 | 0.710 | 0.280 | |
| 每股派息 (元) * | 0.100 | -60.00% | 0.400 | 0.200 | 0.150 | 0.198 | |
| 每股淨資產 (元) * | 9.509 | -1.34% | 9.813 | 9.675 | 9.312 | 8.762 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 13/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
